IAIM
GWPH

International Assets Investment Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

International Assets Investment Management’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,588
Closed -$522K – 2197
2021
Q1 		$522K Buy
3,588
+1,071
+43% +$201K 0.05% 324
2020
Q4 		$290K Sell
2,517
-800
-24% -$89.6K 0.05% 295
2020
Q3 		$323K Buy
3,317
+115
+4% +$13.2K 0.08% 231
2020
Q2 		$393K Sell
3,202
-545
-15% -$61.8K 0.09% 205
2020
Q1 		$328K Buy
+3,747
New +$397K 0.1% 192

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $983M AUM 34.23% 1-Year Est. Return

International Assets Investment Management's GWPH Position: Q2 2021 in Review

International Assets Investment Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 3,588 shares — an estimated $522K sold.

International Assets Investment Management first reported a position in GWPH in Q1 2020 and held it in 5 quarters. The position peaked at $522K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • International Assets Investment Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 3,588 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $522K.
  • International Assets Investment Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2020 and held it in 5 quarters.
  • International Assets Investment Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $522K in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.